vs

Side-by-side financial comparison of Apyx Medical Corp (APYX) and Clipper Realty Inc. (CLPR). Click either name above to swap in a different company.

Clipper Realty Inc. is the larger business by last-quarter revenue ($37.1M vs $19.2M, roughly 1.9× Apyx Medical Corp). Apyx Medical Corp runs the higher net margin — -6.8% vs -30.4%, a 23.6% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs -2.6%). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs 1.8%).

Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.

Clipper Equity LLC is a partnership led by David Bistricer and Sam Levinson. The firm owns more than 60 buildings, with thousands of residential units, in New York and New Jersey. The partnership are known for their attempted purchase of the Starrett City housing complex in Brooklyn, New York, for $1.3 billion on February 8, 2007, in one of the largest real estate transactions in history. New York's Mayor Michael Bloomberg expressed concerns over the new landlord's history of building violati...

APYX vs CLPR — Head-to-Head

Bigger by revenue
CLPR
CLPR
1.9× larger
CLPR
$37.1M
$19.2M
APYX
Growing faster (revenue YoY)
APYX
APYX
+37.3% gap
APYX
34.7%
-2.6%
CLPR
Higher net margin
APYX
APYX
23.6% more per $
APYX
-6.8%
-30.4%
CLPR
Faster 2-yr revenue CAGR
APYX
APYX
Annualised
APYX
36.8%
1.8%
CLPR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
APYX
APYX
CLPR
CLPR
Revenue
$19.2M
$37.1M
Net Profit
$-1.3M
$-11.3M
Gross Margin
62.6%
-5.2%
Operating Margin
0.1%
21.8%
Net Margin
-6.8%
-30.4%
Revenue YoY
34.7%
-2.6%
Net Profit YoY
71.9%
-938.6%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APYX
APYX
CLPR
CLPR
Q4 25
$19.2M
$37.1M
Q3 25
$12.9M
$37.7M
Q2 25
$11.4M
$39.0M
Q1 25
$9.4M
$39.4M
Q4 24
$14.2M
$38.0M
Q3 24
$11.5M
$37.6M
Q2 24
$12.1M
$37.3M
Q1 24
$10.2M
$35.8M
Net Profit
APYX
APYX
CLPR
CLPR
Q4 25
$-1.3M
$-11.3M
Q3 25
$-2.0M
$-4.6M
Q2 25
$-3.8M
$-1.4M
Q1 25
$-4.2M
$-35.1M
Q4 24
$-4.6M
$-1.1M
Q3 24
$-4.7M
$-1.1M
Q2 24
$-6.6M
$-1.7M
Q1 24
$-7.6M
$-2.7M
Gross Margin
APYX
APYX
CLPR
CLPR
Q4 25
62.6%
-5.2%
Q3 25
64.4%
23.6%
Q2 25
62.3%
27.8%
Q1 25
60.1%
-34.5%
Q4 24
63.0%
28.8%
Q3 24
60.5%
28.6%
Q2 24
61.7%
26.8%
Q1 24
58.1%
25.4%
Operating Margin
APYX
APYX
CLPR
CLPR
Q4 25
0.1%
21.8%
Q3 25
-6.5%
23.6%
Q2 25
-22.6%
27.7%
Q1 25
-32.4%
-59.9%
Q4 24
-21.4%
28.1%
Q3 24
-31.6%
28.6%
Q2 24
-45.7%
26.8%
Q1 24
-64.6%
25.4%
Net Margin
APYX
APYX
CLPR
CLPR
Q4 25
-6.8%
-30.4%
Q3 25
-15.4%
-12.2%
Q2 25
-33.2%
-3.5%
Q1 25
-44.0%
-89.1%
Q4 24
-32.5%
-2.9%
Q3 24
-40.9%
-2.9%
Q2 24
-54.0%
-4.7%
Q1 24
-74.0%
-7.5%
EPS (diluted)
APYX
APYX
CLPR
CLPR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$-0.19
Q1 24
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APYX
APYX
CLPR
CLPR
Cash + ST InvestmentsLiquidity on hand
$31.7M
$30.8M
Total DebtLower is stronger
$37.5M
Stockholders' EquityBook value
$14.5M
$-30.7M
Total Assets
$66.8M
$1.2B
Debt / EquityLower = less leverage
2.58×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APYX
APYX
CLPR
CLPR
Q4 25
$31.7M
$30.8M
Q3 25
$25.1M
$26.1M
Q2 25
$29.3M
$32.0M
Q1 25
$31.0M
$21.3M
Q4 24
$31.7M
$19.9M
Q3 24
$28.0M
$18.6M
Q2 24
$32.7M
$20.3M
Q1 24
$37.3M
$21.9M
Total Debt
APYX
APYX
CLPR
CLPR
Q4 25
$37.5M
Q3 25
$37.5M
Q2 25
$37.5M
Q1 25
$37.5M
$1.3B
Q4 24
$37.5M
$1.3B
Q3 24
$37.5M
$1.3B
Q2 24
$1.2B
Q1 24
$1.2B
Stockholders' Equity
APYX
APYX
CLPR
CLPR
Q4 25
$14.5M
$-30.7M
Q3 25
$5.8M
$-25.0M
Q2 25
$7.3M
$-21.9M
Q1 25
$10.5M
$-20.1M
Q4 24
$14.2M
$-5.4M
Q3 24
$11.0M
$-3.6M
Q2 24
$14.7M
$-1.8M
Q1 24
$20.3M
$279.0K
Total Assets
APYX
APYX
CLPR
CLPR
Q4 25
$66.8M
$1.2B
Q3 25
$57.4M
$1.2B
Q2 25
$58.2M
$1.2B
Q1 25
$60.2M
$1.3B
Q4 24
$64.8M
$1.3B
Q3 24
$60.7M
$1.3B
Q2 24
$65.4M
$1.3B
Q1 24
$70.7M
$1.3B
Debt / Equity
APYX
APYX
CLPR
CLPR
Q4 25
2.58×
Q3 25
6.41×
Q2 25
5.17×
Q1 25
3.57×
Q4 24
2.64×
Q3 24
3.40×
Q2 24
Q1 24
4396.73×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APYX
APYX
CLPR
CLPR
Operating Cash FlowLast quarter
$-2.5M
$22.6M
Free Cash FlowOCF − Capex
$-2.8M
FCF MarginFCF / Revenue
-14.6%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-9.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APYX
APYX
CLPR
CLPR
Q4 25
$-2.5M
$22.6M
Q3 25
$-3.5M
$1.4M
Q2 25
$-1.2M
$8.4M
Q1 25
$-702.0K
$6.7M
Q4 24
$-2.9M
$31.9M
Q3 24
$-4.4M
$6.3M
Q2 24
$-4.3M
$8.8M
Q1 24
$-6.3M
$6.3M
Free Cash Flow
APYX
APYX
CLPR
CLPR
Q4 25
$-2.8M
Q3 25
$-4.1M
Q2 25
$-1.5M
Q1 25
$-757.0K
$-4.6M
Q4 24
$-3.2M
$-37.9M
Q3 24
$-4.6M
Q2 24
$-4.6M
Q1 24
$-6.4M
$-14.7M
FCF Margin
APYX
APYX
CLPR
CLPR
Q4 25
-14.6%
Q3 25
-31.5%
Q2 25
-13.2%
Q1 25
-8.0%
-11.7%
Q4 24
-22.4%
-99.5%
Q3 24
-40.0%
Q2 24
-38.0%
Q1 24
-62.2%
-41.1%
Capex Intensity
APYX
APYX
CLPR
CLPR
Q4 25
1.4%
Q3 25
4.0%
Q2 25
2.3%
Q1 25
0.6%
28.6%
Q4 24
1.7%
183.3%
Q3 24
1.3%
Q2 24
2.4%
Q1 24
0.3%
58.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

APYX
APYX

Segment breakdown not available.

CLPR
CLPR

Residential Segment$30.8M83%
Commercial Real Estate$6.2M17%

Related Comparisons